| Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. | lung, |
| addiction (dependence on a single oncogene) to the mutationally activated EGFR in human lung cancer cells | lung, |
| Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. | glioma, |
| Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. | sarcoma,lung, |
| ZIP is a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis | breast, |
| ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis. | breast, |
| Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. | glioblastoma, |
| neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. | breast, |
| Oncogenic EGFR signaling networks in glioma. | glioma, |
| Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain. | glioblastoma, |
| Incidence of the L858R and G719S mutations of the epidermal growth factor receptor oncogene in an Ecuadorian population with lung cancer. | lung, |
| Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. | lung, |
| Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells. | kidney, |
| Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer. | gastric, |
| Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer. | colorectal, |
| Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. | glioma, |
| Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells. | gastric, |
| Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation. | colorectal, |
| cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer. | lung, |
| Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. | glioma, |